Position in RAPP
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$34,043
+$1,034 QoQ
Shares Held
1,088
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RAPP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Tidemark, LLC holds $651,056 across 18 Biotechnology names. RAPP ranks #4 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
567 | $438,086 | |
| 2 | AUPH |
Aurinia Pharmaceuticals Inc.
|
4,340 | $64,318 | |
| 3 | IMRX |
Immuneering Corp
|
10,000 | $52,700 | |
| 4 | RAPP |
Rapport Therapeutics, Inc.
This page
|
1,088 | $34,043 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
288 | $18,613 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
280 | $13,319 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
26 | $11,610 | |
| 8 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
320 | $7,923 |
All Filings in RAPP
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $34,043 | 1,088 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $33,009 | 1,088 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $32,313 | 1,088 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $12,370 | 1,088 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $10,912 | 1,088 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $19,301 | 1,088 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $22,282 | 1,088 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $25,306 | 1,088 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||